Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Wages, Salaries and Other

Lemaitre Vascular (LMAT) Long-Term Debt Repayments (2019 - 2021)

Lemaitre Vascular (LMAT) has disclosed Long-Term Debt Repayments for 4 consecutive years, with $78.0 million as the latest value for Q4 2021.

Quarterly Long-Term Debt Repayments rose 271.43% to $78.0 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $78.0 million through Sep 2022, up 533.33% year-over-year, with the annual reading at $39.0 million for FY2021, 56.0% up from the prior year.
Long-Term Debt Repayments for Q4 2021 was $78.0 million at Lemaitre Vascular, up from -$23.0 million in the prior quarter.
The five-year high for Long-Term Debt Repayments was $78.0 million in Q4 2021, with the low at -$23.0 million in Q3 2021.
Average Long-Term Debt Repayments over 3 years is $9.7 million, with a median of $4.0 million recorded in 2019.
Peak annual rise in Long-Term Debt Repayments hit 271.43% in 2021, while the deepest fall reached 675.0% in 2021.
Over 3 years, Long-Term Debt Repayments stood at $4.0 million in 2019, then soared by 425.0% to $21.0 million in 2020, then soared by 271.43% to $78.0 million in 2021.
According to Business Quant data, Long-Term Debt Repayments over the past three periods came in at $78.0 million, -$23.0 million, and -$9.0 million for Q4 2021, Q3 2021, and Q2 2021 respectively.